MDFSX
Price
$7.46
Change
-$0.19 (-2.48%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

MDFSX vs RMFCX

Header iconMDFSX vs RMFCX Comparison
Open Charts MDFSX vs RMFCXBanner chart's image
Manning & Napier Disciplined Value S
Price$7.46
Change-$0.19 (-2.48%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
MDFSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDFSX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDFSX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. MDFSX (185M). MDFSX pays higher dividends than RMFCX: MDFSX (2.73) vs RMFCX (1.69). MDFSX was incepted earlier than RMFCX: MDFSX (13 years) vs RMFCX (23 years). MDFSX is a more actively managed with annual turnover of: 35.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than MDFSX: RMFCX (250) vs MDFSX (2000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. MDFSX (5.51). RMFCX return over 5 years is better than : 40.39 vs. MDFSX (9.72).
MDFSXRMFCXMDFSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD4.80511.42342%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets185M98.7B0%
Annual Yield % from dividends2.731.69161%
Returns for 1 year5.5112.6344%
Returns for 3 years-5.0114.16-35%
Returns for 5 years9.7240.3924%
Returns for 10 years-18.3061.84-30%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc